Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline and TUDCA in Transthyretin Amyloid Cardiomyopathy
NCT01855360Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline, tauroursodeoxycholic acid in transthyretin amyloid cardiomyopathy (ATTR-CM), sponsored by Brigham and Women's Hospital. Started Jun 2013; status: completed.
02
Drugs
doxycyclinetauroursodeoxycholic acid
03
Conditions
transthyretin amyloid cardiomyopathy (ATTR-CM)
Beyond the preview
Go deeper on NCT01855360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855360.